Network meta‐analysis of Chinese herb injections combined with FOLFOX chemotherapy in the treatment of advanced colorectal cancer

ConclusionsMost of the included studies were of low quality, and there was a scarcity of eligible trials and numbers of participants. Based on currently limited evidence, aidi, shenqifuzheng and compound matrine were superior to other CHIs in patients receiving FOLFOX chemotherapy for advanced CRC. More studies are required to confirm the efficacy of CHIs in combination with FOLFOX for advanced CRC. We firstly carried out a network meta‐analysis to assess the clinical efficacy and safety of Chinese herb injections (CHIs) combined oxaliplatin, 5‐fluorouracil and leucovorin (FOLFOX) for advanced colorectal cancer (CRC) to determine which is the best CHIs. We included 63 studies involving 4837 patients. Based on currently limited evidence, aidi, shenqifuzheng and compound matrine were superior to other CHIs in patients of FOLFOX chemotherapy for advanced CRC.
Source: Journal of Clinical Pharmacy and Therapeutics - Category: Drugs & Pharmacology Authors: Tags: Review Article Source Type: research